 |
|
autologous dendritic cell-adenovirus p53 vaccine
An autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor gene-modified virus. When the autologous dendritic cell-adenovirus p53 vaccine is administered, the host cytotoxic T lymphocytes (CTL) are directed against p53-positive tumor cells, which may result in tumor cell death and decreased tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
|
|
